Profound Medical (PROF) announced that it has entered into an exclusive distribution and supply agreement for its TULSA-PRO system with Getz Healthcare, a leading distributor of medical devices, equipment and consumables, in Australia and New Zealand. “Like in many other regions around the globe, prostate cancer is the most commonly diagnosed cancer in men in Australasia,” said Arun Menawat, Profound’s CEO and Chairman. “We are excited to gain access to this significant market for TULSA-PRO. Beyond Australia and New Zealand, we are actively pursuing other potential opportunities to expand our strategic commercial partnership with Getz Healthcare to include additional key markets across Asia Pacific.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROF:
- Profound Medical Expands into Saudi Arabia with Exclusive Distribution Agreement
- Profound Medical (PRN) Q3 Earnings Cheat Sheet
- Profound Medical Reclaims Canadian Distribution Rights for TULSA-PRO®
- Profound Medical regains exclusive distribution rights for Tulsa-Pro in Canada
- Profound Medical Celebrates 500th TULSA Procedure Milestone at Busch Center